News|Articles|April 3, 2025
Q1 2025 Recap: Allergy
Author(s)Chelsie Derman
Fact checked by: Victoria Johnson
Q1 2025 allergy updates: FDA approved the first omalizumab biosimilar, and experts shared insights on peanut immunotherapy and food allergy treatments.
Advertisement
Advertisement
The first quarter of 2025 was informative for allergists worldwide, with hundreds attending the annual American Academy of Allergy, Asthma, & Immunology (AAAAI) meeting in San Diego (February 28 – March 3).
Advertisement
Advertisement